3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34986429 | Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. | 2022 Mar | 2 |
| 2 | 33645457 | Targeting allosteric pockets of SARS-CoV-2 main protease Mpro. | 2021 Feb 27 | 1 |
| 3 | 32441299 | Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy. | 2020 Jun 26 | 2 |